ArticleJournal of robotic surgery2021
Robotic surgery in treatment of retroperitoneal tumors. Comparative single center study.
Article in Journal of robotic surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Robotic-assisted compartmental dissection for retroperitoneal sarcoma: a feasibility study on cadavers with the da Vinci Xi system.Journal of robotic surgery · 2026Article
- Article
- Article
- Primary anastomosing hemangioma as a preoperative diagnostic mimicker of retroperitoneal cavernous hemangioma: A case report.Oncology letters · 2024Article
- Open versus robot-assisted retroperitoneal tumors resection involving inferior vena cava, abdominal aorta, and renal hilum: a comparative study.Surgical endoscopy · 2024Article
- Robot-Assisted Laparoscopic Removal of a Large Primary Retroperitoneal Mature Cystic Teratoma in an Adult.Cureus · 2021Article
- Periureteral Liposarcoma Causes of Hydroureter and Hydronephrosis: An Unpredictable Diagnosis.Gynecology and minimally invasive therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retroperitoneal tumors (RT)-group of benign and malignant mesenchymal tumors without any specific organ affiliation. Surgery is the only effective treatment. Robotic surgery is becoming popular and an effective approach in abdominal surgery. There is insufficient data about robotic treatment of retroperitoneal tumors. The comparative retrospective study of the results of surgical treatment of RTs between 2009 and 2019 was performed. 88 patients were surgically treated. The average age of patients was 58 (21;85). Clinical manifestations of RT were presented in 59 (67.1%) cases. RTs were asymptomatic in 29 patients (32.9%). The preoperative diagnosis was based on radiological diagnostic methods. Depending on the surgical approach, patients were divided into 3 groups. 35 patients were operated with robot-assisted (RA) method, 14 with laparoscopic (L), and 39 with traditional (TA) open approach. TA had the least operation time, but the most amount of blood loss. The median duration of postoperative drainage, morbidity rate, and postoperative length of stat were less after robotic approaches. The conversion rate was significantly less in robotic group in comparison with laparoscopy. There were no postoperative mortalities after each approach. The robot-assisted surgery could be successfully used in cases of retroperitoneal tumors. It's feasible, safe, and comfortable for patients. The RA significantly reduces risks in cases when the tumor is located in hard-to-reach small spaces and/or attached to the main vessels and the size of the tumor is less than 10 cm.
Indexed as
Identifiers
32602025What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.